Please provide your email address to receive an email when new articles are posted on . 37.4% of patients with Fitzpatrick skin types IV to VI and 38.7% of the total ...
HORSHAM, Pa., June 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...
SCENESSE® is being evaluated as a systemic repigmentation therapy for vitiligo patients, with a clinical focus on adolescent (12 years and above) and adult patients with darker skin types (Fitzpatrick ...
A new review compares topical, laser, and microneedling based stretch marks treatments, highlighting combination therapies that improve striae appearance across Fitzpatrick skin types with better ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results